TickerFacts.

Biolife Solutions Inc (BLFS): Total Assets

Annual figures by period end, from SEC filings.

$405.88M
As of 2025-12-31
$447.49M
As of 2026-06-30
-3.4%
3-year compound annual growth
+11.6%
5-year compound annual growth
+41.8%
10-year compound annual growth
$554.29M2010-12-31: $1.31M2011-12-31: $1.66M2012-12-31: $3.17M2013-12-31: $3.35M2014-12-31: $16.07M2015-12-31: $12.37M2016-12-31: $7.93M2017-12-31: $12.14M2018-03-31: $12.29M2018-06-30: $21.79M2018-09-30: $46.45M2018-12-31: $45.47M2019-03-31: $48.07M2019-06-30: $51.30M2019-09-30: $83.79M2019-12-31: $92.82M2020-12-31: $234.83M2021-12-31: $554.29M2022-12-31: $450.23M2023-12-31: $412.71M2024-12-31: $399.49M2025-12-31: $405.88M$405.88M
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$405.88M+1.6%2026-02-26, Balance as of period end
2024-12-31$399.49M-3.2%2026-02-26, Balance as of period end
2023-12-31$412.71M-8.3%2025-03-03, Balance as of period end
2022-12-31$450.23M-18.8%2024-02-29, Balance as of period end
2021-12-31$554.29M+136.0%2023-03-31, Balance as of period end
2020-12-31$234.83M+153.0%2022-03-31, Balance as of period end
2019-12-31$92.82Mn/a2021-03-31, Balance as of period end
2019-09-30$83.79Mn/a2020-05-15, Balance as of period end
2019-06-30$51.30Mn/a2020-05-15, Balance as of period end
2019-03-31$48.07Mn/a2020-05-15, Balance as of period end
2018-12-31$45.47Mn/a2020-05-15, Balance as of period end
2018-09-30$46.45Mn/a2020-05-15, Balance as of period end
2018-06-30$21.79Mn/a2020-05-15, Balance as of period end
2018-03-31$12.29Mn/a2020-05-15, Balance as of period end
2017-12-31$12.14M+53.2%2019-03-15, Balance as of period end
2016-12-31$7.93M-35.9%2018-03-09, Balance as of period end
2015-12-31$12.37M-23.0%2017-03-15, Balance as of period end
2014-12-31$16.07M+379.3%2016-02-25, Balance as of period end
2013-12-31$3.35M+5.8%2015-03-12, Balance as of period end
2012-12-31$3.17M+90.7%2014-02-12, Balance as of period end
2011-12-31$1.66M+27.0%2013-03-29, Balance as of period end
2010-12-31$1.31Mn/a2012-03-29, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Biolife Solutions Inc (BLFS)2025-12-31$405.88M+1.6%
Vaso Corp (VASO)2025-12-31$88.35M+6.5%
Ceribell, Inc. (CBLL)2025-12-31$195.80M-13.1%
Outset Medical, Inc. (OM)2025-12-31$264.50M-4.1%
Electromed, Inc. (ELMD)2026-06-30$66.27M+23.2%
Iridex Corp (IRIX)2026-01-03$29.15M+0.1%
Axogen, Inc. (AXGN)2025-12-31$221.69M+8.8%
Stereotaxis, Inc. (STXS)2025-12-31$52.25M+11.8%
electroCore, Inc. (ECOR)2025-12-31$18.67M-8.8%

Compare BLFS, VASO, CBLL, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗